The Tepezza hearing loss lawsuits will involve evidence and testimony that will likely be repeated throughout more than 200 claims being pursued against the drug makers.
Each side submitted a list of four claims they believe should be prepared for a series of early Tepezza hearing loss bellwether trials, which are expected to begin in March 2026.
Parties were supposed to pick several potential bellwether Tepezza hearing loss lawsuits this month, but problems with discovery have led to delays.
New Jersey man alleges manufacturer stalled adding Tepezza hearing damage warnings to the label, even after the FDA determined such injuries could be permanent.
Hearing aids may help reduce strain on the brain from hearing loss, and reduce the risk of cognitive decline or other effects of Parkinson’s.
Tepezza hearing loss lawyers claim counsel representing the drug maker tried to coach a company employee during depositions and interfere with interviews.
Manufacturer argues that nearly all claims presented in the Tepezza hearing loss lawsuits selected for bellwether trials should be dismissed based on federal preemption
Court-ordered mediation sessions will be held every three months, to explore the potential for Tepezza hearing loss settlements in advance of the first trial dates.
Horizon failed to instruct doctors to conduct routine hearing tests on patients to monitor for signs of hearing impairment from Tepezza, lawsuit states.
A series of four Tepezza hearing loss lawsuits will go to trial between March 9, 2026 and August 24, 2026, to help determine the average payout juries may award and promote settlement negotiations
